BioLineRx Ltd - Company Profile
Powered by 
All the data and insights you need on BioLineRx Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date BioLineRx Ltd Strategy Report
- Understand BioLineRx Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on BioLineRx Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4117704A4 | Search Report | Cxcr4-hemmer zur behandlung von akutem atemnotsyndrom und virusinfektionen | A61K2300/00; A61K31/13; A61K31/395; A61K31/522; A61K31/662; A61K31/7056; A61K31/706; A61K38/10; A61K38/21; A61K45/06; A61P11/00; A61P11/16; A61P31/14; C07K14/52; C07K7/64; Y02A50/30 | April 10, 2024 |
| IL282317B2 | Grant | Treatment of metastatic pancreatic adenocarcinoma | A61K2039/505; A61K2039/54; A61K2039/545; A61K2300/00; A61K31/4745; A61K31/513; A61K31/519; A61K38/10; A61K38/12; A61K39/3955; A61K45/06; A61P1/18; A61P35/00; A61P35/04; C07K16/2818 | April 01, 2024 |
| US20240092827A1 | Application | Process for manufacturing peptide | C07K1/042; C07K1/10; C07K1/20 | March 21, 2024 |
| US20240082348A1 | Application | Composition of bl-8040 | A61K38/12; A61P35/00 | March 14, 2024 |
| IL308722A | Application | Treatment of metastatic pancreatic adenocarcinoma | A61K2039/505; A61K2039/54; A61K2039/545; A61K2300/00; A61K31/4745; A61K31/513; A61K31/519; A61K38/10; A61K38/12; A61K39/3955; A61K45/06; A61P1/18; A61P35/00; A61P35/04; C07K16/2818 | January 01, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer